From transcriptional regulation to drugging the cancer epigenome
View/
Author
Published Version
https://doi.org/10.1186/s13073-014-0123-1Metadata
Show full item recordCitation
Bradner, James E. 2014. “From transcriptional regulation to drugging the cancer epigenome.” Genome Medicine 6 (12): 123. doi:10.1186/s13073-014-0123-1. http://dx.doi.org/10.1186/s13073-014-0123-1.Abstract
Jay Bradner discusses the opportunities and challenges for the study and therapeutic targeting of the cancer epigenome, as well as innovative approaches to drug discovery.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295578/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:13890713
Collections
- HMS Scholarly Articles [17842]
Contact administrator regarding this item (to report mistakes or request changes)